Vonderheid EC - Search Results

1

Association between Sézary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma.

Abrams JT, Balin BJ, Vonderheid EC. Abrams JT, et al. Among authors: vonderheid ec. Ann N Y Acad Sci. 2001 Sep;941:69-85. doi: 10.1111/j.1749-6632.2001.tb03712.x. Ann N Y Acad Sci. 2001. PMID: 11594584

2

Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Abrams JT, Vonderheid EC, Kolbe S, Appelt DM, Arking EJ, Balin BJ. Abrams JT, et al. Among authors: vonderheid ec. Clin Diagn Lab Immunol. 1999 Nov;6(6):895-905. doi: 10.1128/CDLI.6.6.895-905.1999. Clin Diagn Lab Immunol. 1999. PMID: 10548583 Free PMC article.

3

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA. Vonderheid EC, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):207-20. doi: 10.1016/s0190-9622(98)70597-3. J Am Acad Dermatol. 1998. PMID: 9486676

4

The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.

Vonderheid EC, Ekbote SK, Kerrigan K, Kalmanson JD, Van Scott EJ, Rook AH, Abrams JT. Vonderheid EC, et al. J Invest Dermatol. 1998 Jun;110(6):946-50. doi: 10.1046/j.1523-1747.1998.00206.x. J Invest Dermatol. 1998. PMID: 9620303 Free article.

5

Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.

Abrams JT, Lessin SR, Ghosh SK, Nowell PC, Ju W, Vonderheid EC, Rook AH, DeFreitas E. Abrams JT, et al. Among authors: vonderheid ec. J Immunol. 1991 Mar 1;146(5):1455-62. J Immunol. 1991. PMID: 1847162

6

A clonal CD4-positive T-cell line established from the blood of a patient with Sézary syndrome.

Abrams JT, Lessin S, Ghosh SK, Ju W, Vonderheid EC, Nowell P, Murphy G, Elfenbein B, DeFreitas E. Abrams JT, et al. Among authors: vonderheid ec. J Invest Dermatol. 1991 Jan;96(1):31-7. doi: 10.1111/1523-1747.ep12514693. J Invest Dermatol. 1991. PMID: 1987293 Free article.

7

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.

Kasprzycka M, Zhang Q, Witkiewicz A, Marzec M, Potoczek M, Liu X, Wang HY, Milone M, Basu S, Mauger J, Choi JK, Abrams JT, Hou JS, Rook AH, Vonderheid E, Woetmann A, Odum N, Wasik MA. Kasprzycka M, et al. J Immunol. 2008 Aug 15;181(4):2506-12. doi: 10.4049/jimmunol.181.4.2506. J Immunol. 2008. PMID: 18684941 Free PMC article.

8

Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma.

Ghosh SK, Abrams JT, Terunuma H, Vonderheid EC, DeFreitas E. Ghosh SK, et al. Among authors: vonderheid ec. Blood. 1994 Oct 15;84(8):2663-71. Blood. 1994. PMID: 7522638 Free article.

9

The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.

Rook AH, Kubin M, Fox FE, Niu Z, Cassin M, Vowels BR, Gottleib SL, Vonderheid EC, Lessin SR, Trinchieri G. Rook AH, et al. Among authors: vonderheid ec. Ann N Y Acad Sci. 1996 Oct 31;795:310-8. doi: 10.1111/j.1749-6632.1996.tb52680.x. Ann N Y Acad Sci. 1996. PMID: 8958942

10

The role for interleukin-12 therapy of cutaneous T cell lymphoma.

Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman ML. Rook AH, et al. Among authors: vonderheid ec. Ann N Y Acad Sci. 2001 Sep;941:177-84. doi: 10.1111/j.1749-6632.2001.tb03721.x. Ann N Y Acad Sci. 2001. PMID: 11594571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page